Morris Christelle, Wittmann Jürgen, Jäck Hans-Martin, Jalinot Pierre
LBMC, UMR5239 CNRS-ENS de Lyon, IFR 128 Biosciences Lyon Gerland, 46 Allée d'Italie, 69364 Lyon cedex 07, France.
EMBO Rep. 2007 Jun;8(6):596-602. doi: 10.1038/sj.embor.7400955. Epub 2007 Apr 20.
The mammalian integration site 6 (INT6) protein has been implicated in breast carcinogenesis and characterized as the eIF3e non-core subunit of the translation initiation factor eIF3, but its role in this complex is not known. Here, we show that INT6 knockdown by RNA interference strongly inhibits nonsense-mediated messenger RNA decay (NMD), which triggers degradation of mRNAs with premature stop codons. In contrast to the eIF3b core subunit, which is required for both NMD and general translation, INT6 is only necessary for the former process. Consistent with such a role, immunoprecipitation experiments showed that INT6 co-purifies with CBP80 and the NMD factor UPF2. In addition, several transcripts known to be upregulated by UPF1 or UPF2 depletion were also found to be sensitive to INT6 suppression. From these observations, we propose that INT6, in association with eIF3, is involved in routing specific mRNAs for degradation.
哺乳动物整合位点6(INT6)蛋白与乳腺癌发生有关,并且被鉴定为翻译起始因子eIF3的eIF3e非核心亚基,但其在该复合物中的作用尚不清楚。在此,我们表明,通过RNA干扰敲低INT6可强烈抑制无义介导的信使RNA衰变(NMD),NMD会触发带有提前终止密码子的mRNA的降解。与NMD和一般翻译都需要的eIF3b核心亚基不同,INT6仅对前一过程是必需的。与此作用一致,免疫沉淀实验表明INT6与CBP80和NMD因子UPF2共纯化。此外,还发现一些已知因UPF1或UPF2缺失而上调的转录本对INT6抑制也敏感。基于这些观察结果,我们提出INT6与eIF3相关联,参与将特定mRNA导向降解。